MSD ITALIA S.R.L.
Patent Owner
Stats
- 57 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Aug 22, 2017 most recent publication
Details
- 57 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,177 Total Citation Count
- Mar 23, 1998 Earliest Filing
- 11 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9573939 Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseasesAug 16, 12Feb 21, 17[A61K, C07D]
9549917 Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseasesAug 16, 12Jan 24, 17[A61K, C07F, C07D]
9265773 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseasesAug 20, 12Feb 23, 16[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0328,799 COMPOSITIONS USEFUL FOR THE TREATMENT OF VIRAL DISEASESAbandonedOct 26, 12Nov 06, 14[A61K]
2014/0094,405 CHOLESTEROL DERIVATIVES OF INHIBITORS OF VIRAL FUSIONAbandonedSep 10, 13Apr 03, 14[C07K]
2013/0273,081 VACCINATION AGAINST PCSKK 9 FOR LOWERING CHOLESTEROLAbandonedMar 25, 11Oct 17, 13[A61K]
8198426 Hepatitis c virus replicons and replicon enhanced cellsExpiredJan 16, 02Jun 12, 12[C07H, C12N]
8183216 Nucleoside derivatives as inhibitors of viral polymerasesExpiredSep 16, 08May 22, 12[A61K, C07H, A01N]
2009/0104,220 Method to Make a Peptide-Carrier Conjugate with a High ImmunogenicityAbandonedDec 10, 04Apr 23, 09[A61K, G01N, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.